Investing
FTC Commissioners yet to meet on Amgen-Horizon deal – CNBC
© Reuters. FILE PHOTO: An Amgen sign is seen at the company’s office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith/
(Reuters) – Commissioners at the U.S. Federal Trade Commission (FTC) have not yet met to discuss Amgen (NASDAQ:)’s acquisition of Horizon Therapeutics (NASDAQ:), CNBC reported on Tuesday.
The news comes a day after reports that the FTC is expected to file a lawsuit as early as Tuesday to block the $27.8 billion deal.
Read the full article here
-
Side Hustles6 days ago
United Airlines Adding Starlink, Free WiFi to All Flights
-
Passive Income5 days ago
Reduce Your Business Expenses With This $30 Microsoft Office Alternative
-
Side Hustles7 days ago
There’s a Burnout Crisis in American Workplaces — and This Is the Solution
-
Passive Income7 days ago
Correct Your Spelling Errors on PDFs With This All-in-One PDF Tool
-
Personal Finance6 days ago
Inflation hits 2.5% in August, keeping the Fed on track to lower interest rates
-
Passive Income4 days ago
Sam’s Club Membership Went Down to Just $15 for a Year
-
Investing6 days ago
Professionals Can Securely Organize Their Files With This Cloud Storage Solution
-
Side Hustles5 days ago
How to Create and Maintain a Positive and Respectful Work Environment